Whitepaper: Obesity clinical trial insights from the Antidote patient database
![woman and doctor discussing obesity clinical trials woman and doctor discussing obesity clinical trials](https://www.antidote.me/hubfs/a-worried-female-nutritionist-suggests-a-diet-plan-for-an-overweight-woman.jpg_s=1024x1024%26w=is%26k=20%26c=V6b_Xbs2EDE5CNhOxuJzDM1I8_bF05hH5wmYhkg0NgM=.jpg)
Obesity, a medical condition characterized by an increased amount of body fat, impacts nearly 3 in 4 adults over the age of 20 in the United States. Most commonly defined as a Body Mass Index (BMI) over 30, it is a chronic condition that can negatively impact many aspects of a person’s health.
While many individuals living with obesity have tried multiple methods for losing weight, finding an effective weight management strategy is often difficult. An amalgamation of behaviors, societal norms, socioeconomic status, genetics, and family history can cause obesity. Additionally, reduced cardiopulmonary fitness and the presence of obesity-related pain can limit a person’s activity, resulting in compounding difficulties in a person’s effort to lower their BMI.
Given these complex factors and the prevalence of obesity, continued research is vital to better understanding this condition and developing new treatments and therapies to address it. Antidote’s most recent whitepaper shares insights from our patient database that can lead to successful research, including demographics, research participation motivation, and more. Click the button below to get your free download and view the data.